Metabolomics

Dataset Information

0

Cell Membrane Remodeling Mediates Polymyxin B Resistance in Klebsiella pneumoniae: An Integrated Proteomics and Metabolomics Study


ABSTRACT: Polymyxin B (PB) is introduced into the clinic as the last-line therapy against carbapenem-resistant Klebsiella pneumoniae (CRKP). Unfortunately, increased resistance to PB in Klebsiella pneumoniae (K. pneumoniae) has threatened global health. Resistance of K. pneumoniae to PB was induced by passaging in serial concentrations of PB and determined by microbroth dilution method. Growth characteristics of induced strains including growth curve, reversibility of resistance, and biofilm formation (crystal violet staining method) were measured. This study employed TMT-labeled quantitative proteomics and LC-MS/MS metabolomics analysis to investigate the key biological processes associated with PB resistance in K. pneumoniae. A total of 315 differentially expressed proteins (DEPs) were identified, of which 133 were upregulated and 182 were downregulated in the PB-resistant K. pneumoniae. KEGG enrichment analysis revealed that the DEPs were mainly involved in ATP-binding cassette (ABC) transporters and cationic antimicrobial peptide (CAMP) resistance. Proteins related to central carbon metabolism were inhibited in the PB-resistant K. pneumoniae, but proteins mediating LPS modification were activated. Transcriptional levels of CAMP resistance-related proteins were significantly different between PB-susceptible and -resistant K. pneumoniae. PB treatment led to an increase in reactive oxygen species (ROS) levels of K. pneumoniae. Metabolomics data demonstrated that 23 metabolites were significantly upregulated in PB-resistant K. pneumoniae and 5 were downregulated. The differential metabolites were mainly lipids, including glycerophospholipids, sphingolipids, and fatty acids. Exposure to PB resulted in increased level of phospholipid transport gene mlaF in K. pneumoniae. Our study suggested that membrane remodeling and inhibited central carbon metabolism are conducive to the development of PB resistance in K. pneumoniae.

INSTRUMENT(S): Liquid Chromatography MS - alternating - hilic

SUBMITTER: Xinyi Chen 

PROVIDER: MTBLS4132 | MetaboLights | 2022-03-04

REPOSITORIES: MetaboLights

altmetric image

Publications

Cell Membrane Remodeling Mediates Polymyxin B Resistance in <i>Klebsiella pneumoniae</i>: An Integrated Proteomics and Metabolomics Study.

Chen Xinyi X   Tian Jingjing J   Luo Can C   Wang Xiaofan X   Li Xianping X   Wang Min M  

Frontiers in microbiology 20220210


Polymyxin B (PB) is introduced into the clinic as the last-line therapy against carbapenem-resistant <i>Klebsiella pneumoniae</i> (CRKP). Unfortunately, increased resistance to PB in <i>Klebsiella pneumoniae</i> (<i>K. pneumoniae</i>) has threatened global health. Resistance of <i>K. pneumoniae</i> to PB was induced by passaging in serial concentrations of PB and determined by microbroth dilution method. Growth characteristics of induced strains including growth curve, reversibility of resistanc  ...[more]

Similar Datasets

2022-01-24 | PXD030940 | Pride
2023-10-13 | PXD045685 | JPOST Repository
2017-12-25 | GSE24688 | GEO
2021-02-25 | PXD022220 | Pride
2019-10-17 | GSE138949 | GEO
2022-04-11 | PXD018528 | Pride
2024-01-26 | PXD033020 | Pride
2020-07-01 | GSE153553 | GEO
2014-02-02 | GSE52538 | GEO
2023-04-18 | GSE229867 | GEO